Low income (World Bank) vs Portugal: HPV immunization coverage estimates among primary target cohort (9-14)
Low income (World Bank)
32.0%
in 2025
Portugal
97.0%
in 2025
Low income (World Bank) rank
6th
Portugal rank
5th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Low income (World Bank)
- Portugal
How they compare
Portugal currently reports 97.0% against 32.0% in Low income (World Bank), a difference of 65.0%.
That makes Portugal's figure about 3.0 times Low income (World Bank)'s.
Across all 16 years both countries report, Portugal has been ahead every year.
Low income (World Bank) ranks 6th and Portugal ranks 5th of 11 groups.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Low income (World Bank) | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.4% | 92.3% | 86.9% | Portugal |
| 2020s | 26.3% | 94.0% | 67.7% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Low income (World Bank) or Portugal?
- Portugal, at 97.0% against 32.0% in Low income (World Bank) as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Low income (World Bank) and Portugal?
- 65.0%, with Portugal ahead.
- How many years of comparable data are there for Low income (World Bank) and Portugal?
- 16 years are reported by both, from 2010 to 2025.
- How do Low income (World Bank) and Portugal rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Low income (World Bank) ranks 6th and Portugal ranks 5th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.